☆ 4.7 Article

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

Lindsay Kim et al.

Summary: This study identified factors associated with severe outcomes among adults hospitalized with COVID-19, including age, sex, comorbidities like obesity, immunosuppression, and diabetes. Older age, male gender, and certain underlying conditions were independently linked to increased risk of ICU admission and in-hospital mortality.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States

Pinar Karaca-Mandic et al.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Article Immunology

Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic Review

Tom Jefferson et al.

Summary: This review aimed to investigate the relationship between SARS-CoV-2 culture and RT-PCR results, as well as other variables such as time from symptom onset. The findings suggest that there is a correlation between Ct values, symptom severity, and the ability to culture live virus. It was also noted that those with high Ct values are less likely to have infectious potential.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Robert L. Gottlieb et al.

Summary: The study showed that treatment with bamlanivimab and etesevimab was significantly associated with a reduction in SARS-CoV-2 viral load at day 11 in nonhospitalized patients with mild to moderate COVID-19, compared to placebo. However, bamlanivimab monotherapy did not show a significant reduction in viral load. Ongoing clinical trials will focus on assessing the clinical benefits of antispike neutralizing antibodies in COVID-19 patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19

Orestis A. Panagiotou et al.

Summary: In this cohort study of 5256 US nursing home residents with COVID-19, older age, male gender, and impaired cognitive and physical function were independently associated with increased mortality risk. Identifying these risk factors can help in developing clinical prediction models for mortality in this population.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Letter Virology

Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil

Carolina M. Voloch et al.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

添加到收藏夹

Article Cell Biology

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones et al.

Summary: LY-CoV555 is a novel neutralizing antibody derived from a convalescent patient with COVID-19, showing high affinity binding, potent inhibition of ACE2 binding, and strong neutralizing activity. This antibody has entered clinical trials and is being evaluated for various COVID-19 prevention and treatment indications.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Immunology

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Henry M. Staines et al.

Summary: The study showed that in SARS-CoV-2 infection, 2.0%-8.5% of individuals did not seroconvert 3-6 weeks after infection. Those who did seroconvert were typically older, more likely to have concurrent conditions, and had higher levels of inflammatory markers. Non-White individuals had higher antibody concentrations compared to White individuals, and these concentrations remained stable during follow-up.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Microbiology

Nasal Swab Sampling for SARS-CoV-2: a Convenient Alternative in Times of Nasopharyngeal Swab Shortage

Helene Pere et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Temporal dynamics in viral shedding and transmissibility of COVID-19

Xi He et al.

NATURE MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

Temet M. McMichael et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

M. M. Arons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada

David N. Fisman et al.

JAMA NETWORK OPEN (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

添加到收藏夹

Article Infectious Diseases

SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes

N. S. N. Graham et al.

JOURNAL OF INFECTION (2020)

添加到收藏夹

Letter Medicine, General & Internal

Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities

Elizabeth M. White et al.

JAMA INTERNAL MEDICINE (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.